International Assets Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

International Assets Investment Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-935	Closed	-$85.5K	–	2426
2024 Q2	$85.5K	Buy	+935	New	+$83.5K	0.01%	994
2023 Q4	–	Sell	-2,723	Closed	-$320K	–	815
2023 Q3	$320K	Buy	+2,723	New	+$220K	0.04%	360
2023 Q2	–	Sell	-1,708	Closed	-$310K	–	766
2023 Q1	$310K	Buy	+1,708	New	+$132K	0.04%	365

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FPGK

Financial Partners Group (Kansas) Overland Park, Kansas $985M AUM 29.69% 1-Year Est. Return

International Assets Investment Management's PPH Position: Q3 2024 in Review

International Assets Investment Management sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2024, closing a stake of 935 shares — an estimated $85.5K sold.

International Assets Investment Management first reported a position in PPH in Q1 2023 and held it in 3 quarters. The position peaked at $320K in Q3 2023. 142 funds tracked by Wall St. Rank hold PPH as of Q3 2024.

International Assets Investment Management reported no remaining VanEck Pharmaceutical ETF position as of Q3 2024 after selling out during the quarter.
International Assets Investment Management sold 935 VanEck Pharmaceutical ETF shares in Q3 2024, an estimated $85.5K.
International Assets Investment Management first reported a position in VanEck Pharmaceutical ETF in Q1 2023 and held it in 3 quarters.
International Assets Investment Management's VanEck Pharmaceutical ETF position peaked at $320K in Q3 2023.
142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2024.

Based on International Assets Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.